New Law: requiring the DEA to have REAL PROBABLE CAUSE before acting ?

New US law stymies efforts to control opioids

http://www.newsobserver.com/opinion/editorials/article93159532.html

Congresswoman Judy Chu, a California Democrat, co-sponsored a bill in the U.S. House that met no significant opposition in either her chamber or the U.S. Senate. The new law makes it harder for the government to go after pharmaceutical companies and drug stores that do not report suspicious orders of opioids such as oxycodone and hydrocodone, powerful painkillers.

Before this law, the Drug Enforcement Administration could shut down companies and doctors if the agency determined there was an “imminent danger” to the public. Now, the standard is higher, defining the danger as “substantial likelihood of an immediate threat” of death. And those companies that stand accused of failing to report suspiciously large orders of the drugs now can can submit a “corrective action plan” and avoid punishment by the DEA.

The Los Angeles Times reports that the top DEA administrator for the regulation of pharmaceutical companies resigned last fall in protest of the bill.

Chu, by the way, has gotten more than $31,000 in contributions from the pharmaceutical industry. She had no comment for the Times.

This is an appalling bow to the powerful pharmaceutical industry, with billions of dollars at stake and millions to spend on powerful lobbyists. And it could not have come at a worse time.

Opioid abuse is a public health menace. Nearly 200,000 people have died since 1999 from overdoses involving opioid painkillers. In North Carolina, the figure is 1,000 deaths – each year. And state health officials report that is a more than 300 percent increase. Abuse of the drugs has, The Times reports, been linked to a destructive and deadly surge in heroin use.

The new law means that alarms sound for companies only after the DEA makes accusations. What should happen, of course, is the creation of a regulatory system offering severe punishments for companies that don’t closely monitor, and regularly report, suspicious orders – unusually large ones, for example.

The fact that there is a serious black market for opioids is a tremendous problem.

The companies that manufacture them aren’t being asked to go out of business; they’re being told to be responsible to the public and to do their duty. That isn’t too much to ask. Congress should revisit this unfortunate and irresponsible law as soon as possible.

CHASING the “opiate epidemic” GHOST ?


Authorities organize new, unified effort to end opioid epidemic in Pittsburgh

http://www.wpxi.com/web/wpxi/news/law-enforcement-organize-new-unified-effort-to-end-opioid-epidemic-in-pittsburgh/296144726

PITTSBURGH —

Law enforcement is organizing a new, unified push to stop the opioid epidemic in the Pittsburgh area. The effort includes preventing prescription pill abuse, which officials say often leads to heroin addiction.
 
“I never wanted to become a heroin addict. I didn’t wake up one day and said, ‘I want to be a heroin addict,’” Abby Zorsi said.
 
In high school, Zorsi got good grades, played several sports and had good friends. Her problem with addiction started when she had her wisdom teeth removed and was given a prescription for pain killers.
 
“I was prescribed a whole bottle of Vicodin that I just didn’t need. I went through it fast,” Zorsi said.
 
She added that her pain was gone in about three days, but she kept taking the pills.
 
“A week, not even, and I was addicted to these pills, and I didn’t really know it yet,” Zorsi said.
 
She said when she finished the first bottle of pills, getting a refill was easy.
 
“They never questioned me. I don’t think it ever came into their heads that I may be addicted to these,” Zorsi said.
 
Zorsi said when the pills became too expensive, people at school told her about a cheaper high: heroin. In less than a year, she was addicted and stealing from her parents to support her problem.
 
“Nobody wakes up in the morning and says, ‘Gee, I want to be a drug addict today,’” said Dr. John Kabazie, the program director for the Institute for Pain Medicine in Pittsburgh.
 
Kabazie said Zorsi’s story doesn’t surprise him.
 
“The intention is to help the patient and treat the patient, but unfortunately, sometimes we tend to overprescribe and clearly that’s led to the problem we have now,” Kabazie said.
 
He added that the problem is bigger in certain states, such as Pennsylvania, because there is no system in place to successfully monitor doctor-shopping.
 
“If a patient buys or is doctor-shopping in Pennsylvania and they can’t get medication in this state, they can go to another state and then come back here, and we won’t know that,” Kabazie said.
 
At FBI headquarters in Pittsburgh, the plan to attack the problem has changed. From local to federal, all levels of law enforcement now are involved. Agents are being trained to look out for physical traits associated with prescription pill abuse. Still, the one thing missing in Pennsylvania is the prescription drug monitoring program that many states already have in place.
 
“It would be tremendously helpful for the state of Pennsylvania once we are on board with this prescription monitoring program to have a better gauge of the activity,” FBI Supervisory Special Agent Shawn Brokos said.
 

Vote for whoever you want – things won’t change ! OMG !

 Vote all you want. The secret government won’t change.

The people we elect aren’t the ones calling the shots, says Tufts University’s Michael Glennon

The voters who put Barack Obama in office expected some big changes. From the NSA’s warrantless wiretapping to Guantanamo Bay to the Patriot Act, candidate Obama was a defender of civil liberties and privacy, promising a dramatically different approach from his predecessor.

But six years into his administration, the Obama version of national security looks almost indistinguishable from the one he inherited. Guantanamo Bay remains open. The NSA has, if anything, become more aggressive in monitoring Americans. Drone strikes have escalated. Most recently it was reported that the same president who won a Nobel Prize in part for promoting nuclear disarmament is spending up to $1 trillion modernizing and revitalizing America’s nuclear weapons.

Why did the face in the Oval Office change but the policies remain the same? Critics tend to focus on Obama himself, a leader who perhaps has shifted with politics to take a harder line. But Tufts University political scientist Michael J. Glennon has a more pessimistic answer: Obama couldn’t have changed policies much even if he tried.

Though it’s a bedrock American principle that citizens can steer their own government by electing new officials, Glennon suggests that in practice, much of our government no longer works that way. In a new book, “National Security and Double Government,” he catalogs the ways that the defense and national security apparatus is effectively self-governing, with virtually no accountability, transparency, or checks and balances of any kind. He uses the term “double government”: There’s the one we elect, and then there’s the one behind it, steering huge swaths of policy almost unchecked. Elected officials end up serving as mere cover for the real decisions made by the bureaucracy.

Glennon cites the example of Obama and his team being shocked and angry to discover upon taking office that the military gave them only two options for the war in Afghanistan: The United States could add more troops, or the United States could add a lot more troops. Hemmed in, Obama added 30,000 more troops.

Glennon’s critique sounds like an outsider’s take, even a radical one. In fact, he is the quintessential insider: He was legal counsel to the Senate Foreign Relations Committee and a consultant to various congressional committees, as well as to the State Department. “National Security and Double Government” comes favorably blurbed by former members of the Defense Department, State Department, White House, and even the CIA. And he’s not a conspiracy theorist: Rather, he sees the problem as one of “smart, hard-working, public-spirited people acting in good faith who are responding to systemic incentives”—without any meaningful oversight to rein them in.

How exactly has double government taken hold? And what can be done about it? Glennon spoke with Ideas from his office at Tufts’ Fletcher School of Law and Diplomacy. This interview has been condensed and edited.

IDEAS: Where does the term “double government” come from?

GLENNON:It comes from Walter Bagehot’s famous theory, unveiled in the 1860s. Bagehot was the scholar who presided over the birth of the Economist magazine—they still have a column named after him. Bagehot tried to explain in his book “The English Constitution” how the British government worked. He suggested that there are two sets of institutions. There are the “dignified institutions,” the monarchy and the House of Lords, which people erroneously believed ran the government. But he suggested that there was in reality a second set of institutions, which he referred to as the “efficient institutions,” that actually set governmental policy. And those were the House of Commons, the prime minister, and the British cabinet.

IDEAS: What evidence exists for saying America has a double government?

GLENNON:I was curious why a president such as Barack Obama would embrace the very same national security and counterterrorism policies that he campaigned eloquently against. Why would that president continue those same policies in case after case after case? I initially wrote it based on my own experience and personal knowledge and conversations with dozens of individuals in the military, law enforcement, and intelligence agencies of our government, as well as, of course, officeholders on Capitol Hill and in the courts. And the documented evidence in the book is substantial—there are 800 footnotes in the book.

IDEAS: Why would policy makers hand over the national-security keys to unelected officials?

GLENNON: It hasn’t been a conscious decision….Members of Congress are generalists and need to defer to experts within the national security realm, as elsewhere. They are particularly concerned about being caught out on a limb having made a wrong judgment about national security and tend, therefore, to defer to experts, who tend to exaggerate threats. The courts similarly tend to defer to the expertise of the network that defines national security policy.

The presidency itself is not a top-down institution, as many people in the public believe, headed by a president who gives orders and causes the bureaucracy to click its heels and salute. National security policy actually bubbles up from within the bureaucracy. Many of the more controversial policies, from the mining of Nicaragua’s harbors to the NSA surveillance program, originated within the bureaucracy. John Kerry was not exaggerating when he said that some of those programs are “on autopilot.”

IDEAS: Isn’t this just another way of saying that big bureaucracies are difficult to change?

GLENNON: It’s much more serious than that. These particular bureaucracies don’t set truck widths or determine railroad freight rates. They make nerve-center security decisions that in a democracy can be irreversible, that can close down the marketplace of ideas, and can result in some very dire consequences.

IDEAS: Couldn’t Obama’s national-security decisions just result from the difference in vantage point between being a campaigner and being the commander-in-chief, responsible for 320 million lives?

GLENNON: There is an element of what you described. There is not only one explanation or one cause for the amazing continuity of American national security policy. But obviously there is something else going on when policy after policy after policy all continue virtually the same way that they were in the George W. Bush administration.

IDEAS: This isn’t how we’re taught to think of the American political system.

GLENNON: I think the American people are deluded, as Bagehot explained about the British population, that the institutions that provide the public face actually set American national security policy. They believe that when they vote for a president or member of Congress or succeed in bringing a case before the courts, that policy is going to change. Now, there are many counter-examples in which these branches do affect policy, as Bagehot predicted there would be. But the larger picture is still true—policy by and large in the national security realm is made by the concealed institutions.

IDEAS: Do we have any hope of fixing the problem?

GLENNON: The ultimate problem is the pervasive political ignorance on the part of the American people. And indifference to the threat that is emerging from these concealed institutions. That is where the energy for reform has to come from: the American people. Not from government. Government is very much the problem here. The people have to take the bull by the horns. And that’s a very difficult thing to do, because the ignorance is in many ways rational. There is very little profit to be had in learning about, and being active about, problems that you can’t affect, policies that you can’t change.

Texas medical board’s policies and procedures

TMA Board of Councilors Current Opinions

https://www.texmed.org/CurrentOpinions/

ABANDONMENT. The unilateral severance by the physician of the patient-physician relationship without providing an adequate medical attendant or reasonable notice under existing circumstances of the physician’s intent to terminate the patient-physician relationship is abandonment and is unethical. (April. 2003)

COVERAGE OF PRACTICE. Following establishment of a patient-physician relationship, the physician remains responsible for the care of that patient until such time as the patient-physician relationship is ended in a proper and legal manner. It is recommended that a physician provide appropriate care and when a physician is unavailable, communicate to the patient an alternative for care.

DUTY TO DEAL HONESTLY WITH PATIENTS. It is a fundamental ethical requirement that a physician should at all times deal honestly and openly with patients. Patients have a right to know their past and present medical status and to be free of any mistaken beliefs concerning their conditions. Situations occasionally occur in which a patient suffers significant medical complications. In these situations, the physician is ethically required to inform the patient of all the facts necessary to ensure understanding of what has occurred. Only through full disclosure is a patient able to make informed discussions regarding future medical care.

Ethical responsibility includes informing patients of changes in their diagnosis resulting from retrospective review of test results or any other information. This obligation holds even though the patient’s medical treatment or therapeutic options may not be altered by the new information.

AG Lynch: The ability of Americans to have a voice in the direction of their country

cpvotesNorth Carolina voter ID law struck down as ‘discriminatory’ by federal court

The US attorney general, Loretta Lynch, applauded the ruling. Such voting restrictions, she said in a statement, “sent a message that contradicted some of the most basic principles of our democracy”.

She added: “The ability of Americans to have a voice in the direction of their country – to have a fair and free opportunity to help write the story of this nation – is fundamental to who we are and who we aspire to be.”

https://www.theguardian.com/us-news/2016/jul/29/north-carolina-voter-id-law-struck-down?

You can read the rest of the article … IMO.. it is a bunch of political posturing between the two political parties. Can you imagine that the courts have struck down the a person… in order to vote who is representing us in various political position … has to show a valid ID.

If you want to purchase a controlled Rx – you must show a driver’s license

If you wish to purchase tags for your car – you must show a driver’s license

If you wish to purchase insurance for your car – you must show a driver’s license

If you are going to fly commercially – you must show a driver’s license

If you want to write a personal check for a purchase – you mush show a driver’s license

If a cop stops you for a traffic stop – you must show a driver’s license

If you want to purchase a cell phone – you must show a driver’s license

I am sure that many of my readers can think of a dozen or more incidents of the need for a driver’s license

What would prevent a group of people could generate fake driver’s license with different names and addresses and on election day go from voting site to voting site and “stuff the ballot box” with votes for a particular candidate. Otherwise know as VOTER FRAUD…

Most states will issue a “state ID card” … it will look like a driver’s license.. but .. is just a state ID.

Those in the chronic pain community should take AG Lynch’s words to heart who we are and who we aspire to be.

Congress works on a TWO YEAR session.. so that means that since the Controlled Substance Act 1970 was passed… started the war on drugs… we have had 23 Congressional sessions since then..  we have had <D> and <R> Presidents and <D> & <R> majority House/Senate and Congress as a whole..

What has changed for the better or for the worse ?

The war on drugs was ramp up during the 2009-2011 period to focus more on pts, doc, pharmacies, wholesalers… opiate Rxs peaked in 2012… but the DEA changed the scheduling of Vicodin type products in 2014 and OD continue to rise.. so the CDC implemented new guidelines on opiate dosing in 2016.. which is causing more pts to be denied .. and we can only look forward to more “tightening of the screws” in 2018 as OD’s continue to climb.  IMO.. we are having to deal with a bunch of  “brain dead” bureaucrats that are not smart enough that the cause & effect that they have believed to be going on..  which appears that they are DEAD WRONG… They are apparently listening to certain individuals and/or groups that has an profit agenda in treating substance abusers and/or turn chronic pain pts into pts with a “opiate use disorder” and in need of participating in their program.

cryingeyevote

 

At CVS: where judgmental health is everything ?

asseenontheweb

I was just at my neighborhood CVS on Glenwood Rd in Decatur Ga, and am completely floored at what I found out. I went in to buy sunscreen for an outing at a lake tomorrow. After searching high and low for sunscreen, I went up front and asked the cashier where it was. To my surprise, I was told that your company was no longer sending sunscreen to this particular store…when I asked why, I was told because this part of the area doesn’t need or use sunscreen… I live in a predominantly African American area…but I am Caucasian. I’m not sure you are aware that black people’s skin burns just like us white folks. In fact the cashier I was talking to (who is black) lost her uncle to skin cancer. I find this quite disturbing…I applaud you for no longer selling cigarettes because of cancer, but it sure seems stupid on your part to not sell sunscreen, which helps to protect against cancer. I’m sure this will just be put at the bottom of your list, but it’s ridiculous in my books. I hope this changes…I shouldn’t have to go the the “white part” of town to buy a product from your company.
Unhappy consumer,

Could the DEA/FDA legalize MJ while keeping the “black market” HEALTHY ?

baithook Bad News for Marijuana Supporters: The DEA Just Delayed This Critical Decision

The DEA’s decision on cannabis’ scheduling now has no timetable.

http://www.fool.com/investing/2016/07/31/bad-news-for-marijuana-supporters-the-dea-just-del.aspx

The “black drug market” is what keeps Congress funding the DEA.  So the FDA could get the need for a much BIGGER bureaucracy if the DEA rescheduled to C-II.. while putting the legal MJ market place at a financial disadvantage to the illegal black market.. that keeps the DEA “in business”

Overall, it’s been a pretty exceptional two decades for the marijuana industry. Sure, there have been a few bumps in the road, like the failure of a medical marijuana amendment in Florida in 2014. But as a whole, the increasing acceptance of cannabis has been almost constant since 1996.

Since California first legalized medical marijuana for compassionate use in 1996, two dozen states have legalized its medical use — that’s half the country! This year alone, both Ohio and Pennsylvania have legalized the use of medical marijuana for certain ailments, and they both did so through the legislative process (i.e., without putting the issue on the ballot for voters to decide).

On top of the 25 states that have legalized medical cannabis over the past 20 years, four states, along with Washington, D.C., have legalized the use of recreational marijuana since 2012. In Colorado alone, trailing-12-month sales came to $1 billion as of February. Legal marijuana sales generated about $135 million in tax and licensing revenue in Colorado in 2015, much of which will go toward the state’s education program, as well as its law enforcement and drug abuse programs.

And this could just be the tip of the iceberg. Cannabis industry analysts at ArcView Market Research see the industry growing at an average clip of 30% per year through 2020. This takes into account growth from existing industries and the potential for new approvals, including up to a dozen states that will be voting on whether to legalize medical or recreational marijuana in the upcoming November election.

Scientist Writing On Clipboard Marijuana Cannabis Getty
Image source: Getty Images.

This decision is a very big deal

The steady growth of the cannabis industry has been overshadowed by an even more exciting event: the potential rescheduling of medical marijuana by the U.S. Drug Enforcement Agency (DEA).

Currently, the marijuana plant is defined as a schedule 1 substance. This means it has no federally recognized medical benefits and is considered to be an illicit drug. As long as marijuana remains an illicit drug, businesses that sell marijuana face two very big disadvantages.

First, cannabis-based businesses have little to no access to basic financial services. Although banks could probably serve the cannabis industry and add to their profits, most banks fear the potential for legal action from the federal government. Because the marijuana plant is still illegal, allowing a marijuana business to open a checking account or take out a loan could be construed as money laundering. Without access to checking accounts or credit, these businesses are forced to deal primarily in cash, which is both a security concern and an expansion inhibitor.

The other issue for marijuana businesses is that they pay a much higher tax rate than normal businesses. Internal Revenue Service tax code 280E disallows normal tax deductions in instances where the product being sold is illicit. This means companies in the marijuana industry have to pay tax on gross profits, rather than net profits.

If the DEA were to reschedule marijuana to anything other than a schedule 1 substance (i.e., schedule 2 through 5), then cannabis would be deemed to have medically beneficial properties, which would allow physicians throughout the country to prescribe medical marijuana for patients. Furthermore, it would allow medical researchers to study the effects of marijuana on certain diseases without having to jump through a long series of hoops. Presumably, the inherent financial disadvantages would fall by the wayside as well, as banks could serve marijuana businesses without fear of repercussions.

Hourglass Sands Of Time Getty
Image source: Getty Images.

 

Bad news for marijuana supporters

However, the DEA delivered a buzzkill of epic proportions to marijuana supporters last month.

Originally, the DEA was rumored to be making its decision on whether or not to reschedule medical marijuana by July 1, or, as the Santa Monica Observer claimed, Aug. 1. But the DEA is certainly in no rush to make up its mind on what it considers a critical issue.

In an interview with online publication aNewDomain, DEA staff coordinator Russ Baer noted, “What is under-reported right now is how complex the marijuana plant is.” According to aNewDomain, the plant itself contains about 480 compounds, and medical marijuana can be administered in multiple ways, which means the scope of research being conducted by the DEA could be far beyond what marijuana supporters initially expected.

When pressed about the July 1 or Aug. 1 deadlines for a decision, Baer added, “We are not holding ourselves to any artificial timeframe.” However, it is worth noting that the DEA has received the scientific and health recommendations from the Food and Drug Administration that are required as part of its own eight-part review process, which may or may not lead to the rescheduling of cannabis.

So what does this mean for the cannabis industry and the potential for reclassification? Essentially, it means a decision is coming, but it will likely come much later than most people had expected. In other words, for the foreseeable future, the marijuana industry will continue to face inherent disadvantages.

Marijuana On Top Of Money Getty
Image source: Getty Images.

Rescheduling may not be a cure-all for cannabis

Even if the DEA decides to reclassify cannabis from schedule 1 to schedule 2, thereby allowing physicians to prescribe cannabis for certain ailments, a number of different obstacles could arise and obstruct growth for the industry.

The biggest concern is that cannabis will be reclassified as a schedule 2 substance — one that has medical benefits but is considered addictive and prone to abuse. If that happens, then the FDA will have enormous power over the cannabis industry. For example, the FDA could control how the marijuana industry markets to adults, including how packaging material is labeled. It could, and probably would, regularly inspect growing and processing facilities to ensure that consistent manufacturing standards are being met (e.g., consistent THC content).

But most worrisome of all, it could require cannabis businesses to run clinical trials to confirm that marijuana offers the health benefits being advertised. All of these added regulations could be incredibly costly for the cannabis industry, which could wind up pushing smaller players out in favor of bigger businesses that could afford the higher regulatory costs. Strict regulation could also hinder marijuana businesses’ efforts to lower their prices and thus make their products more competitive with black-market alternatives.

Don’t get me wrong: A reclassification to anything other than schedule 1 should be seen as a step forward for the industry. But how big of a step it will be depends on the DEA — if it ever reclassifies the drug at all.

For the time being, marijuana supporters, as well as investors hoping to take advantage of a possible reclassification, would be wise to temper their expectations and exercise some patience, as the DEA is in no rush to issue its decision.

 

Minnesota DHS discriminating against the disabled for YEARS ?

Minnesota DHS discriminating against the disabled for YEARS ?

July 30A federal judge ruled Friday that a class action lawsuit filed by people with disabilities can proceed against the Minnesota Department of Human Services.

The four named plaintiffs allege they represent some 5,000 disabled Minnesotans who have been deprived of over $1 billion in services from a Medicaid program managed by DHS. They claim the Home and Community Based Service Waiver program, which is meant to help disabled people live independently rather than in hospitals or nursing homes, was mismanaged to the point where plaintiffs languished on waiting lists for years or were incorrectly told they were not eligible for funds.

Medicare waivers allow states to spend money that would be used for institutionalization on other services that allow disabled people to live on their own, such as housing and caretaking.

“These are services that have been promised to people with disabilities,” said Shamus O’Meara of O’Meara Leer Wagner & Kohl, the Minneapolis-based law firm that represents the plaintiffs. “The state has the money it has been receiving it for two decades and it just isn’t spending it. It doesn’t spend it and it reverts back to the general fund. We’re not sure precisely sure where the money is going.”

O’Meara said some people have been on waiting lists for 15 years without receiving benefits.

DHS had argued the plaintiffs’ claims should be dismissed, or in the alternative that Minnesota counties should be named as parties as well. The judge rejected that argument, finding that DHS controlled the program in dispute.

The lawsuit was originally filed in August 2015.

Most Governors signed compact to legislate limits on opiate dosing

Bullock one of seven governors not signing NGA’s compact to fight opioid abuse

http://www.kbzk.com/story/32578537/bullock-one-of-seven-governors-not-signing-ngas-compact-to-fight-opioid-abuse

Apparently the vast majority of GOVERNORS believe that you can legislate morality, mental health issues and the treatment of chronic pain.  IMO… what a bunch of  ARROGANT ASS-HOLES !

HELENA –

Gov. Steve Bullock is one of only seven governors who wouldn’t sign a National Governors Association compact to fight a national epidemic of opioid drug addiction and abuse.

The compact, released two weeks ago, outlines steps that states should take to combat the abuse of opioids, such as prescription painkillers, heroin and other such drugs.

“Turning the tide on the epidemic requires a coordinated response across all levels of government and strong leadership from the private sector,” the NGA said when it unveiled the compact.

But the Bullock administration said it objects to two main elements of the compact: Requiring physicians and other health-care professionals to check a state prescription-drug database before prescribing such drugs to any patient, and considering laws to limit certain prescriptions.

Prescription limits are “adamantly opposed” by physicians and pain advocates, and using Montana’s prescription-drug database when prescribing drugs should be voluntary – as it is now, the governor’s office told MTN News.

Jean Branscum, CEO of the Montana Medical Association, which represents physicians, said it believes doctors should check Montana’s prescription-drug database when prescribing painkillers, to see if the patient might be “doctor-shopping” for certain drugs.

Yet the MMA does not believe state law should require physicians to do the checks.

“Leaping into making that a mandate takes us in a different direction, than what we feel is necessary for Montana physicians,” she said Friday.

Montana has had a prescription-drug registry since 2011. The bill creating it was one of Bullock’s top initiatives when he was the state’s attorney general.

Pharmacists are required to file information with the registry on almost every controlled-substance prescription they fill. The registry is meant to track the potential overuse or abuse of certain drugs.

Branscum said Montana’s prescription-drug registry is “still a product in development,” and that the MMA has been working with the state Board of Pharmacy, which runs the registry, to enable physicians’ staff to be able to check it.

That change will help the checks become more easily “built into the work flow” of a doctor’s office, she said.

The MMA also supports extending the registry beyond 2017, when it’s scheduled to expire, and will be seeking a bill in the 2017 Legislature to do that, she added.

As for limiting certain opioid prescriptions, Branscum said state law should not be used to dictate a “standard of practice” by physicians.

The best practices for treating chronic pain are evolving and the MMA is offering continuing education for physicians, she said.

“We want to have education on those best practices and (not) have physicians worry about what the law says is the best practice at the time the law is passed,” Branscum said.

“Physicians agree that there is an opioid epidemic across the nation and that Montana has not been left untouched,” she said. “So physicians are stepping up for the best patient care, without having mandates surrounding that, to take care of the issue.”

She said the MMA also will be supporting efforts to make naloxone more available – a drug used to treat opioid overdoses.

Philippines President: kill the addicts/junkies and drug sellers

Philippines President Makes Good on Pledge to Mass Murder People Who Use or Sell Drugs, Calls for “No Mercy” in State of the Nation Address

http://www.drugpolicy.org/news/2016/07/philippines-president-makes-good-pledge-mass-murder-people-who-use-or-sell-drugs-calls-

Apparently the President of the Philippines is putting together a full blown GENOCIDE.. unlike the USA that is just taking away the pain management of millions of people .. who end up going to the street and dying from using Heroin/Fentanyl street drugs or just commits suicide… which in this process is just more like a “passive genocide ” ?

President Estimates 100,000 People Will Be Killed; Several Hundred Already Executed Extra-Judicially

Drug Policy Alliance: Stop the Philippines Drug War Killings Now

Today, the President of the Philippines delivered his “State of the Nation Address.”  He vowed to show “no mercy” in his bloody war on drugs and crime, warning criminals that priests and human rights advocates cannot protect them from being killed.

Rodrigo Duterte was elected last month after promising to wipe out crime and corruption throughout the country, relying heavily on an anti-drug campaign centered around murdering people who use or sell drugs. Duterte has encouraged law enforcement, and even civilians, to kill people suspected of selling drugs and people who struggle with addiction. He said, “If you know of any addicts, go ahead and kill them yourself as getting their parents to do it would be too painful.”

“I strongly suspect that Filipinos will come to regret their election of a president who expresses such contempt for basic principles of due process and human rights,’ said Ethan Nadelmann, Executive Director of the Drug Policy Alliance. “A government that condones extra-judicial killings of people who use or sell drugs will eventually turn its terror on others – it’s just a matter of time.”

During his campaign, Duterte estimated that 100,000 people would die as a result of this crackdown. According to AFP, Duterte has not been deterred by the human rights concerns opponents have raised about lack of due process. Additionally, as part of his initiative, Duterte promises to fully pardon anyone involved with the killing of people who use or sell drugs. Last week, police announced a plan to erect a large electronic billboard outside their headquarters in Manila that will keep track of all these drug-related killings.

There has been a notable silence from the international community. So far, the only country to weigh in has been China – and they have been supportive of Duterte’s drug policies.

Historically, the Philippines has had a conservative approach to drug policy and maintained harsh drug laws, such as 20 years of imprisonment for possession of 5 grams or more of any type of drug. But Duterte’s approach is unprecedented; he has escalated an already-tough drug policy to the extreme, eliciting terror and violence throughout the country.

“In 1985 I was sentenced to 15 years-to-life for a first time, nonviolent drug offense, and it blows me away to hear about the draconian drug policy that the President of the Philippines is championing,” said Anthony Papa, author of This Side of Freedom and manager of media relations at the Drug Policy Alliance. “We have some terrible drug policies in the U.S., like mandatory minimum sentences, but I have never seen anything like the killings that are happening in the Philippines right now.”